Concepedia

Author

Julia Scarisbrick

NIHR Surgical Reconstruction and Microbiology Research CentreORCID

Also Known As

J J Scarisbrick, J Scarisbrick, J. J SCARISBRICK, J. J. Scarisbrick, J. Scarisbrick, J.J. SCARISBRICK, J.J. Scarisbrick, Julia J Scarisbrick, Julia J. Scarisbrick, Julia Jane Scarisbrick

299

Publications

10.5K

Citations

49

H-Index

53

Concepts

All Affiliations

NIHR Surgical Reconstruction and Microbiology Research CentreSt Thomas' HospitalUniversity of TurinGuy's and St Thomas' NHS Foundation TrustHôpital Saint-Louis
JS

About

Julia Scarisbrick is an author at NIHR Surgical Reconstruction and Microbiology Research Centre specializing in medicine, dermatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

32

3.6K

2

Health Sciences

3

3

275

3

Allergy

1

1

12

4

Biology

1

1

56

5

Cell Biology

1

1

36

Julia Scarisbrick

×

72

Publications

8.1K

Citations

44

H-Index

YearCitations

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

Nita Agar, Emma Wedgeworth, Siobhan Crichton,

Journal of Clinical Oncology

2010

826

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Sean Whittaker, Marie‐France Demierre, Ellen J. Kim,

Journal of Clinical Oncology

2010

650

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown,

The Lancet Oncology

2018

621

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer,

The Lancet

2017

569

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer,

Journal of Clinical Oncology

2015

407

<scp>D</scp>iagnosis and management of acute graft‐versus‐host disease

Fiona L. Dignan, Andrew Clark, Persis Amrolia,

British Journal of Haematology

2012

302

Guidelines on the use of extracorporeal photopheresis

Robert Knobler, Gösta Berlin, Piergiacomo Calzavara‐Pinton,

Journal of the European Academy of Dermatology and Venereology

2013

217

The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

Julia Scarisbrick, Pietro Quaglino, H. Miles Prince,

British Journal of Dermatology

2018

216

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

Julia Scarisbrick, Peter C. Taylor, Udo Holtick,

British Journal of Dermatology

2008

174

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma

Julia Scarisbrick, Sean Whittaker, A. V. Evans,

Blood

2001

164

Page 1